(Updates with the stock move in the headline and the first paragraph.)
Celsius (CELH) shares were up nearly 33% in premarket activity Friday after the company overnight reported a beat on Q4 earnings and sales and announced the acquisition of Alani Nutrition.
The company reported Q4 adjusted diluted earnings late Thursday of $0.14 per share, versus $0.17 a year earlier.
Analysts polled by FactSet expected $0.12.
Revenue for the quarter ended Dec. 31 was $332.2 million, compared with $347.4 million a year earlier.
Analysts surveyed by FactSet expected $326.2 million.
The company also announced the acquisition of Alani Nutrition for $1.8 billion. When accounting for $150 million in tax assets, the net purchase price would be $1.65 billion, the company said.
The purchase price will be paid $1.28 billion in cash and $500 million in stock, plus a $25 million earn-out based on 2025 performance, Celsius said.
Celsius will use $900 million in debt and approximately $375 million in cash on hand to finance the acquisition.
The purchase is expected to close in Q2, Celsius said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.